Loading clinical trials...

Can CT Enteroclysis Predict the Outcome of Crohn's Disease | Clinical Trials | Clareo Health

COMPLETED

Can CT Enteroclysis Predict the Outcome of Crohn's Disease

Can CT Enteroclysis Predict the Response to Therapy and Outcome in Patient With Crohn's Disease

NCT00572780•Indiana University

Summary

Specific CT Enteroclysis findings with or without other clinical and laboratory variables, can identify Crohn's disease patients who will response to medical therapy versus those who will either fail and require surgery or have uncontrolled disease.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Crohn's disease with CT Enteroclysis during symptomatic treatment

Exclusion Criteria

•Crohn's disease subjects who have had a follow-up less than 1 year, without surgery
•Crohn's disease subjects that were later diagnosed with a bowel malignancy

Locations (1)

Indiana University

Indianapolis, Indiana, United States

Key Dates

Start Date

August 1, 2007

Primary Completion Date

January 1, 2012

Completion Date

January 1, 2012

Last Updated

August 10, 2015

Enrollment

125

ACTUAL participants

Conditions

Crohn's Disease

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

NCT06226883

Inflammatory Bowel DiseasesCrohn's Disease

View study

RECRUITINGPHASE3

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

NCT07184931

Crohn's Disease

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 10, 2015Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Can CT Enteroclysis Predict the Outcome of Crohn's Disease

Inclusion Criteria

Exclusion Criteria

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease

Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas w/ Crohn's Disease